{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:55Z","timestamp":1791828595158,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare condition. Its treatment remains a challenge for clinicians, and often yields mixed results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case<\/jats:title>\n                <jats:p>We report the case of a 51-year-old Caucasian woman who presented with SAPHO syndrome with mainly axial involvement. She had been treated with sulfasalazine and anti-inflammatory drugs for many years without any success. A few weeks after starting treatment with tofacitinib, both clinical and biological parameters dramatically improved. Imaging also showed considerable regression of the vertebral and pelvic lesions. However, tofacitinib had to be discontinued due to the occurrence of pulmonary embolism. Consequently, recurrence of bone pain and biologic inflammation was rapidly observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Anti-JAKs are an interesting treatment option in the management of SAPHO syndrome that need further clinical trials and assessment for validating response.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-024-04366-w","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T01:33:08Z","timestamp":1708047188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9062-679X","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Dierckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Nisolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Boutsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"4366_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011149","volume":"97","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhao Y, Li C, Luo Y, Hao W, Zhang W. Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine (Baltimore). 2018;97: e11149.","journal-title":"Medicine (Baltimore)"},{"issue":"4527","key":"4366_CR2","first-page":"34","volume":"8","author":"B Li","year":"2020","unstructured":"Li B, Li GW, Xue L, Chen YY. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: a case report. World J Clin Cases. 2020;8(4527):34.","journal-title":"World J Clin Cases"},{"issue":"2151","key":"4366_CR3","first-page":"8","volume":"36","author":"F Cianci","year":"2017","unstructured":"Cianci F, Zoli A, Gremese E, Ferraccioli G. Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment. Clin Rheumatol. 2017;36(2151):8.","journal-title":"Clin Rheumatol"},{"issue":"254","key":"4366_CR4","first-page":"65","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum. 2012;42(254):65.","journal-title":"Semin Arthritis Rheum"},{"issue":"1104","key":"4366_CR5","first-page":"8","volume":"18","author":"MF Kahn","year":"1991","unstructured":"Kahn MF, Bouvier M, Palazzo E, Tebib JG, Colson F. Sternoclavicular pustulotic osteitis (SAPHO). 20-year interval between skin and bone lesions. J Rheumatol. 1991;18(1104):8.","journal-title":"J Rheumatol"},{"key":"4366_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-016-0583-y","volume":"18","author":"D Firinu","year":"2016","unstructured":"Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco SR. SAPHO syndrome: current developments and approaches to clinical treatment. Curr Rheumatol Rep. 2016;18:35.","journal-title":"Curr Rheumatol Rep"},{"issue":"648","key":"4366_CR7","first-page":"54","volume":"44","author":"W Xu","year":"2017","unstructured":"Xu W, Li C, Zhao X, et al. Whole-spine computed tomography findings in SAPHO syndrome. J Rheumatol. 2017;44(648):54.","journal-title":"J Rheumatol"},{"issue":"5","key":"4366_CR8","doi-asserted-by":"publisher","first-page":"394.e9","DOI":"10.1016\/j.crad.2020.12.005","volume":"76","author":"LH Zhang","year":"2021","unstructured":"Zhang LH, Han SB, Song L, Gao S, Zhao Q, Deng XL, Yuan HS. Comparative analysis and differentiation between SAPHO syndrome and spondyloarthropathies using whole-spine MRI. Clin Radiol. 2021;76(5):394.e9-394.e14.","journal-title":"Clin Radiol"},{"issue":"1699","key":"4366_CR9","first-page":"1704","volume":"37","author":"K Ben Abdelghani","year":"2010","unstructured":"Ben Abdelghani K, Dran DG, Gottenberg JE, Morel J, Sibilia J, Combe B. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol. 2010;37(1699):1704.","journal-title":"J Rheumatol"},{"issue":"733","key":"4366_CR10","first-page":"5","volume":"84","author":"D Wendling","year":"2017","unstructured":"Wendling D, Aubin F, Verhoeven F, Prati C. IL-23\/Th17 targeted therapies in SAPHO syndrome. A case series. Joint Bone Spine. 2017;84(733):5.","journal-title":"Joint Bone Spine"},{"issue":"663","key":"4366_CR11","first-page":"9","volume":"37","author":"C Li","year":"2019","unstructured":"Li C, Zhao Y, Zuo Y, et al. Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. Clin Exp Rheumatol. 2019;37(663):9.","journal-title":"Clin Exp Rheumatol"},{"issue":"392","key":"4366_CR12","first-page":"6","volume":"69","author":"S Guignard","year":"2002","unstructured":"Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine. 2002;69(392):6.","journal-title":"Joint Bone Spine"},{"issue":"9","key":"4366_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/annrheumdis-2020-217250","volume":"79","author":"Y Li","year":"2020","unstructured":"Li Y, Huo J, Cao Y, Yu M, Zhang Y, Li Z, Li C, Zhang W. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis. 2020;79(9):1255\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"4366_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911922","volume":"25","author":"F Yuan","year":"2022","unstructured":"Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. Front Immunol. 2022;25(13): 911922.","journal-title":"Front Immunol"},{"key":"4366_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217854","volume":"81","author":"W Xie","year":"2022","unstructured":"Xie W, Huang H, Zhang Z. Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome. Ann Rheum Dis. 2022;81: e91.","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04366-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T01:33:21Z","timestamp":1708047201000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04366-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4366"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04366-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publication of this case report has been accepted by the ethics committee of CHU UCL Namur Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}